No Data
No Data
Mydecine Innovations Group Inc. Announces Share for Debt Settlement
Oregon House Passes Bill to End Hard Drug Decriminalization
There are many factors in setting drug policy, which often center around the benefits or detriments to a society and its economy.
Mydecine Innovations Closes Partial Debt Settlement
Mydecine Innovations Group (0NF0.F) completed a partial settlement for its outstanding debts to an unnamed creditor, according to a Friday filing. The biotechnology company settled a $52,370.86 debt b
Psychedelic Stocks Gain After FDA Priority Review for MDMA Therapy
Mydecine Innovations Group Receives Two Notice of Allowances From USPTO for Its MYCO-005 and MYCO-006 Family of Compounds
VANCOUVER, British Columbia, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. ("Mydecine" or the "Company") (CSE:MYCO) (AQSE:MYIG) (OTC:MYCOF) (FSE:0NF0), a leading biotechnology co
Mydecine Innovations Group Receives Notice of Allowance From USPTO for Its MYCO-005 Compound
VANCOUVER, British Columbia, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. ("Mydecine" or the "Company") (CSE:MYCO) (AQSE:MYIG) (OTC:MYCOF) (FSE:0NFA), a forefront biotechnology
No Data